首页> Nature> Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

导出 OA

翻译打印收藏纠错

第一作者： Christina,Guo

第一单位： The Institute of Cancer Research, London, UK.;The Royal Marsden NHS Foundation Trust, London, UK.

作者： Christina,Guo ^[1] ; Adam,Sharp ^[1] ; Bora,Gurel ^[2] ; Mateus,Crespo ^[2] ; Ines,Figueiredo ^[2] ; Suneil,Jain ^[3] ; Ursula,Vogl ^[4] ; Jan,Rekowski ^[2] ; Mahtab,Rouhifard ^[2] ; Lewis,Gallagher ^[2] ; Wei,Yuan ^[2] ; Suzanne,Carreira ^[2] ; Khobe,Chandran ^[1] ; Alec,Paschalis ^[1] ; Ilaria,Colombo ^[4] ; Anastasios,Stathis ^[5] ; Claudia,Bertan ^[2] ; George,Seed ^[2] ; Jane,Goodall ^[2] ; Florence,Raynaud ^[2] ; Ruth,Ruddle ^[2] ; Karen E,Swales ^[2] ; Jason,Malia ^[2] ; Denisa,Bogdan ^[2] ; Crescens,Tiu ^[1] ; Reece,Caldwell ^[6] ; Caterina,Aversa ^[6] ; Ana,Ferreira ^[2] ; Antje,Neeb ^[2] ; Nina,Tunariu ^[6] ; Daniel,Westaby ^[1] ; Juliet,Carmichael ^[1] ; Maria Dolores,Fenor de la Maza ^[1] ; Christina,Yap ^[2] ; Ruth,Matthews ^[2] ; Hannah,Badham ^[2] ; Toby,Prout ^[2] ; Alison,Turner ^[2] ; Mona,Parmar ^[2] ; Holly,Tovey ^[2] ; Ruth,Riisnaes ^[2] ; Penny,Flohr ^[2] ; Jesus,Gil ^[7] ; David,Waugh ^[8] ; Shaun,Decordova ^[2] ; Anna,Schlag ^[2] ; Bianca,Calì ^[9] ; Andrea,Alimonti ^[10] ; Johann S,de Bono ^[11]

作者单位： The Institute of Cancer Research, London, UK.;The Royal Marsden NHS Foundation Trust, London, UK. ^[1] The Institute of Cancer Research, London, UK. ^[2] Northern Ireland Cancer Centre, Belfast, UK.;Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. ^[3] Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland. ^[4] Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland. ^[5] The Royal Marsden NHS Foundation Trust, London, UK. ^[6] MRC London Institute of Medical Sciences (LMS), London, UK.;Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK. ^[7] Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.;Centre for Cancer Biology, University of South Australia, Adelaide, South Australia, Australia. ^[8] Institute of Oncology Research, Bellinzona, Switzerland. ^[9] Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.;Institute of Oncology Research, Bellinzona, Switzerland.;Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich (ETH), Zurich, Switzerland.;Department of Medicine, Veneto Institute of Molecular Medicine, University of Padova, Padua, Italy. ^[10] The Institute of Cancer Research, London, UK. johann.debono@icr.ac.uk.;The Royal Marsden NHS Foundation Trust, London, UK. johann.debono@icr.ac.uk. ^[11]